Application Note

 

Maximizing productivity in biopharmaceutical research and clinical development

 

Researchers utilizing immunoassays throughout the biotherapeutics development process are looking for:

  • High quality data for confident decisions
  • Fast turn around time to results
  • Rapid assay development
  • Robust assays
  • Low sample consumption
  • High throughput 

We present three examples that show how Gyrolab systems contribute to developing biopharmaceutical drugs faster and with less cost and effort.

 

Case study 1: Obtaining an entire PK profile from a single mouse

 

Case study 2: Earlier and more sensitive detection of drug-induced kidney toxicity in preclinical studies

 

Case study 3: Ramping up Phase II/III PK studies to meet critical deadlines


If you have problems downloading the poster please contact:

 

maritha.lundin@gyrosproteintech.com

 

Please register to dowload the application note